1st Exam Flashcards
Mediators of vasodilation:
Protoglandins, NO, Histamine, and C3a and C5a
mediators of increased vascular permeability:
histamine, sreotonin, C3a and C5a, Bradykinin, Leukotrienes C4, D4, E4, PAF, Substance P, prostaglandin
mediators of chemotaxis:
C3a and C5a, Cytokines TNF, IL-1, Leukotrienes B4 (LTB4), Bacterial Products, chemokines, IL-8
mediators of fever:
prostoglandins, cytokines TNF, IL-1
mediators of pain:
prostoglandins, bradykinin, substance P
mediators of tissue damage:
NO, Lysosomal enzyes, ROS Chemokines
Effects of prostoglandin:
fever, pain, vasodilaiton, increased vascular permeability (at least PGD2 and PGE2)
Effects of NO:
Tissue damage, vasodilation
Effects of histamine:
Vasodilation, increased vascular permeability
Effects of serotonin:
increased vascular permeability, vasod, and vasoc (if injury to bv, primary hemostasis, clotting)
Effectes of C3a, C5a:
vasodilation, increased vascular permeability, chemotaxis
Effects of bradykinin:
increased vascular permeability, pain, (vasod and bronchial sm contraction?)
Effects of Leukotrienes C4, D4, and E4:
Increased vascular permeability
effects of PAF:
Increased vascular permeability, aggregate platelets, degranulation (release of pre-formed mediators), bonchoconstriction, vasod (1000 X more than histamine), chemotaxis of inflammatory cells
Effects of Substance P
Increased (LL says modulate), vascular permeability, pain, regulate vessel tone, stimulate cytokine P and R
Effects of cytokines TNF, IL-1:
chemotaxis, fever
Effects of Leukotrienes B4:
chemotaxis:
Effects of Bacterial products:
chemotaxis
Effects of lysosomal enzymes:
Tissue damage
Effects of ROS:
Tissue damage
Effects of chemokines:
chemotaxis and tissue damage
Paraneoplastic syndrome(s) assoc w lung small cell anaplastic (oat cell) carcinoma:
Cushing Syndrome, Hyponatremia
Paraneoplastic syndrome(s) assoc w various carcinomas:
Troussea Syndrome, hypoglycemia
Paraneoplastic syndrome assoc w Lung ssc:
hypercalcemia
Paraneoplastic syndrome assoc w renal cell carcinoma:
polycythemia (increased concentration of hemoglobin)
Paraneoplastic syndrome assoc w metastatic malignant carcinoid tumors;
Carcinoid syndrome
Mechanism of Cushing Syndrome (cortisol levels too high cause CS):
ACTH-like substnace
Mechanism of hypercalcemia:
PTH-like hormone
Mechanism of hyponatremia:
innappropriate ADH secretion
Mechanism of polycythemia:
erythropoeitin-lke substance
Mechanism of Trousseau syndrome:
hypercoagulable state
Mechanism of hypoglycemia:
insulin-like substance
Mechanism of carcinoid syndroe
5-hydroxy-indoleacetic acid
15% of ppl w dermatomyositis get:
carcinoma of lung, ovary, breast
Tumor assoc w migratory venous thrombosis:
pancreatic carcinoma
Tumor assoc w Myasthenia gravis:
thymoma, thymus tumor
dermatomyositis:
heliotropic (directs toward the sun) rash on malar (cheek) surface of face, ai disease, inflammatory, affects bv, m atrophy
PSA is a marker for:
Prostate cancer
AFP is a marker for:
Hepatocellular carinoma
CEA is a marker for:
colon carcinoma
hCG is a marker for:
choriocarcinoma, tumor of uterus, originates from chorion of fetus (human chorionic gonadotropin)
PLAP is a marker for:
Seminoma, malignant tumor of testis (balls fFLAP) (from primordial germ cells of sexually undifferentiated embryonic gonad. (I thought -‘oma’ ‘s were benign?)
Health issues that cause chronic inflammation:
persistent infections/toxins, ai disorders
4 pw acute inflammation can go down:
CHAR: Chronic, Healing, Abscess, Resolution
Histamine is released by:
mast, basophils, and platelets
2 main descriptors of inflammatory mediators:
pleiotropic and redundant
Why do we need so many mediators with overlapping effects?
they are all short lived, leads to amplification
From where are mediator derived?
cell or plasma
7 cell derived mediators:
VAN PELCC: Vasoactive amines, neuropeptides, prostaglandins, enzymes, leukotrienes, cytokines, chemokines,
3 plasma-derived mediators of inflammation:
complement, coagulation, and kinin systems (3 ‘C’ sounds) mp
2 vasoactive amines:
histamine and serotonin
Preformed mediators:
Vasoactive amines (histamine, serotonin) and leukocyte lysosomal enzyme
3 neutral proteases:
elastase, collagenase, cathepsin (endopeptidase found in most cells, autolysis and self-digestion of tissues)
Major sources of newly formed mediators:
leukocytes, mast cells, endothelial cells, platelets (LMEndoP)
How are newly formed mediators removed from body?
enzymes or spontaneous decay
This liberates AA from the cell if there is cell injury (cell membrane I think):
phospholipase
2 pathways for AA metabolism:
cyclooxygenase and 5-Lipoxygenase
cyclooxygenase pw to metabolize AA:
Thromboxane A2: vasoc, platelet agg/ Prostacyclin: vasod, inhibit platelet agg/ PGD2 and PGE2: vasod, inc perm/ pain and fever
5-Hete:
Part of 5-Lipoxygenase pw to breakdown AA, recruits inflammatory cells via chemotaxis
5-Lipoxygenase pw of AA metabolism:
5-Hete: recruits inflammatory cells, leukotrienes A4-E4: asthma and increased vascular permeability, Lipoxin A4, B4: inhibits neutrophil adhesion and chemotaxis
Acids besides AA being metabolized via this pw:
Omega 3 and 6 fatty acids
Group of natural antiinflammatory mediators:
resolvins, natural antagonists to prostaglandins
Why do steroids decerase inflammation?
prevent liberation of AA
2 cyclooxygenase inhibitor (Cox-1, Cox-2):
aspirin (NSAIDS), indometacin
Newly synthesized mediators of inflammation:
AA, PAF, cytokines, chemokines, neuropeptides, ROS, NO (CNNCRAP)
PAG is aka:
AGEPC
PAF is derived from:
phospholipid
Sources of PAF:
platelets, PMN, mast cells, macros, endothelium (PPEMM)
What liberates PAF?
activation of phospholipase A2
Families of cytokines:
lymphokines, monokines, chemokines, interleukins, interferons (3 kines and 2 I’s)
4 major cytokines in acute inflammation:
TNF, IL-1, IL-6, and chemokines
Major cytokines of acute inflammation are produced by (3):
macros, mast cells, endo cells
Major cytokines in chronic inflammation:
IL-12, INF-gamma
Effect of IL-1 and 6 on liver:
production of acute phase proteins
Effect of IL-1 and 6 on brain:
fever
Effect of IL-1 and 6 on bone marroe:
Wbc production
3 Systemic protective effects of acute inflammation (IL-1 and 6):
fever, wbc production, and acute phase protein production (TNF also promotes fever and wbc prod)
5 Pathological systemic effects of TNF:
low heart output, hypertension, shock, thrombus formation, insulin resistance of skeletal muscle (IL-1 also causes insulin resistance)
5 Systemic mani of inflammation:
fever, leukocytosis, inc acute-phase proteins, decrease apetite, inc sleep (FLAPPAS)
4 Fxn of chemokines:
wbc recruitement, cellular organization, active (sic?) leukocytes, regulate cell trafficking
How do chemokines interact with cells?
receptors
2 newly synthesized neuropeptides:
sub P and calcitonin gene related protein (CGRP)
Neurogenic inflammation occurs when these are activated:
neuropeptides (transmit pain)
Effect of CGRP
(Calcitonin gene related protein) vasod, pain
Sources of ROS:
activated PMN’s and macros
How are ROSs synthesized?
NADPH oxidase pw
Effect of low level secretion of ROS:
inc chemokine, cytokine, adhesion molecule expression
Effect of high level secretion of ROS:
endothelial damage, inc perm, protease activation, antiprotease inactivation
What limits the toxicity of secreted ROS?
endogenous antioxidant mechanisms
NO is found in:
endo cells, macros
System(s) activated by Hageman factor:
Complement, Kinin-Bradykinin, Coagulation (all 3 plasma mediators of inflammation)
Fxn of plasma-protein derived mediators of inflammation:
inc perm, vasoactive
This activates fibrinogen:
thrombin
2 ways to activate the complement cascade:
plasmin or kallikrein (not hageman factor?)
Endogenous antimediators that “stop” inflammation:
antioxidnats, lipoxins, protease inhibitors (PAL)
This interleukin inhibtis TNF:
IL-10
These interleukins promote repair:
IL-2, IL-4
WHat do NSAID’s do?
block COX-1 and Cox-2 (from making PG’s)
What do steroids do?
prevent AA release by PLA2
What do Etanercept and Infiximab do?
block TNF (RA and Crohn’s)
Causes of infection (inflammation?)
physical, chemical, infection, immune reaction, ischemia
Type of inflammation depends on:
chronology and pathology
Vasoactive mediators that cause gaps due to endothelial contraction:
histamine, leukotrienes, etc.
4 mechanisms of inflammation permeability:
endothelial gaps, necrosis/apoptosis, leukocyte-dependent injury, transcytosis
Selectins are involved in these cellular events:
rolling, activation (P, E, and L selectins_)
Integrins/Immunoglobulins are involved in these cellular events:
activation, adhesion
PECAM-1 is involved in this cellular event:
transmigration (synonymous with transcytosis?)
List of integrins/Immunoglobulins involved in cellular events:
MAC 1, ICAM 1, VCAM-1, LFA 1, VLA-4
These recognize sialylated carbohydrate groups:
selectins
This selectin is stored in Weibel–Palade bodies of endothelial cells:
P selectin
This selectin is not produced under normal conditions:
E selectin
These are the ligands to the homing receptors of lymphocytes and determine which tissues the lymphos will enter next:
addressins
Plays a key role in removing aged neutrophils from body:
PECAM-1 (involved in transmigration)
4 major groups of adhesion molecules:
selectins, addressins, integrins, immunoglobulin superfamily
Mechanism of acute inflammation molecule adhesion:
P and E selectin (ELAM-1), then ICAM-1 bind Lewis X (CD15) on WBC’s (check, I think ICAM-1 bonds something else)
What cause P seletins to be expressed on endothelial cell surface?
thrombin (or histamine?) act on W-P (Wiebel-Palade) bodies on the bvs, leads to inflammation (vWF is also store in W-P bodies, homeostasis)
Where is L selectin expressed?
lymphocyte
Mechanism of chronic adhesion molecules:
CD34 (w Lewis X on it) binds L-selectin (on lymphos), ICAM-1 binds CD18 (lyphos and monos), and some acute adhesion molecules
PECAM is involved in:
transmigration (diapadesis)
PECAM is aka:
CD31, on both endo and lymphos
How does PECAM pierce the basement membrane to allow diapadesis of the WBC?
collegenase
How does a cell relocate during chemotaxis?
by binding ecm
Chemotactic pw:
C5a binds G-protein CR, phospholipase C which activates both phosphatidyl-inositol bisphosphate and inositol 3-phosphate, I3P then increases Ca2+, actin and myosin build and aide in motility, inc number and affinity of adhesion molecules
Bradykinin is broken down via:
kininases
Where are the mediators for the cascading enzyme systems synthesized?
liver
How is fibrin broken down?
plasminogen cascade
How to determine if there is a clot somewhere in he body via blood draw?
look for fibrin split products
Activators of Hageman factor(4):
platelets, necrosis, collagen, bm
Increased intracellular Ca+ concentration can lead to:
Inc expression of endonuclease (DNA), ATPase (energy), protease (protein) , phospholipase (membrane)
Trigger formation of the inflamasome:
bacterial endotoxins, necrosis, cytokines
Function of the inflamasome:
activate proteases
Function of pyrin:
antiinflammatory
Function of corticosteroids:
block AA synthesis (blocking inflammation) (and steroid prevent the release from the lipid membrane…?)
4 major groups of antiinflammatory drugs:
antihistamines, corticosteroids, NSAIDS, Leukotriene drugs
Function of Leukotriene drugs:
5-lipoxygenase inhibitors (zileuton), LT receptor antagonist (Accolate)
Cells of acute and chronic inflammation:
acute: polys, chronic: lymphos, macros, and plasma
Sub-acute inflammation is characterised by:
polymorphous granulation tissue
Specific causes of granulomatous inflammation:
TB, fungus, sutures, syphilis
Contributes to the formation of granulomas:
IL-4 (Th2 cells)
water + mucus, nasal discharge:
catarrhal
Pus + polys:
purulent
pseudomembranous:
dead cells + polys
governs the increased production and release of neutrophils from the marrow during inflammation:
IL-1 and TNF
Normal WBC count:
4,500-11,000 cells/mm^3
Blood test for inflammation or leukocytosis:
WBC differential count
Causes of neutrophilic leukocytosis:
infection, inflammation, necrosis
Shift to the left:
BM cells release immature forms of polys
Lymphocytic leukocytosis:
polys aren’t increased, chronic inflammatory process, ie TB, viral diseaese
This type of leukocytosis is common with allergic reactions, parasitic infections:
eosinophilic leukocytosis
3 types of leukocytosis:
neutrophilic lymphocytic, eosinophilic
4 ex of acute phase reactants:
Fibrinogen, globulins, CRP, protein SAA (transport cholesterol to liver for secretion into bile, recruit immune cells to inflammatory sites, induce enzymes that degrade ECM)
How to test for bacterial inflammation:
Blood PCT level (procalcitonin)
Is CRP elevated in acute or chronic inflammation?
Both
When would blood ESR level be high?
Infection and systemic inflammatory disease (erythrocyte sedimentation rate, nonspecific test for inflammation)
ESR results that indicate inflammation:
RBC travel further than 20mm
Prime stimulant of CRP:
IL-6
CRP is produced here:
liver
Elevated blood SAA levels indicate:
chronic infammatory disease
Protein SAA is stimulated by:
IL-1 and TNF (if these are mediators of acute, do they decrease in numbers once protein SAA identification initiated? I would have thought they would need to be present for continued expression of P SAA)
Protein SAA has a tendency to form:
fibrils (amyloidosis), diagnose with congophilic dyes
Calcitonin is made by these cells:
C cells of thyroid gland
When does granulation tissue form?
as inflammation subsides
Granulation tissue is composed of:
proliferating capillaries, fibroblast, and myofibroblasts, amorphous ECM, and macros
Sitmulate angiogenesis:
VEGF and betaFGF (made by macros, betafibroblast growth factor)
Activates the transcription of VEGF and B-FGF
hypoxia-induced factors (HIF)
These are responsible for wound contraction:
myofibroblasts derived from pericytes
Amorphous ECM is made by, and contains lots of:
fibroblasts, glucosamines looks acellular
Function of HIF:
induce VEGF and BFGF
Effects of VEGF and BFGF:
proteolysis of ECM, migration, chemotaxis, proliferation of endo cells, lumen formation, maturation and inhibition of growth, and increased permeability (gaps and transcytosis)
Antagonist of Angiopoietin 1:
Angiopoietin 2, tube regression
How does granulation tissue become scar tissue?
Organization of fibroblasts and collagen fibrils in tissue
Scars form through:
the remodelling of granulation tissue
How is granulation tissue broken down?
matrix metalloproteinases
2 inhibitors of angiogenesis:
angiopoietin 2 adn angiostatin
Wound contraction starts at day __ and usually ends by day__:
3, 30
Granulation tissue starts to form at day __ and usually ends by day__:
0.3, 10
How long does it take for inflammation to start?
about 0.1 days: 2.4 hrs
Early wound collagen is Type __ and late wound collagen is converted to type __
III, I
Which type of collagen is stronger, Type I or Type III?
I
dehiscence:
Reopening of wound, esp. scar tissue